We then demonstrated that NF‐κB was indeed a novel activator for WDR6 transcription in HCC cells by using the NF‐κB inhibitor IMD0354 and ChIP assays (Fig 5Eiii and Eiv). The gene discussed is WDR6; the disease is hepatocellular carcinoma.